Hospital-focused biopharmaceutical company
Investors 2
Mentions in press and media 3
| Date | Title | Description |
| 02.11.2010 | Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV(TM) (Acetaminophen) Injection for the Management of Pain and Fever | November 2 , 2010
San Diego, CA — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OFIRMEV(TM) (acetaminophen) injection, the first and only in... |
| 18.02.2009 | Public biotech firms Cadence, Affymax draw $128M from bargain-hunting VCs | Much has been written about how the IPO market froze out biotech companies in 2008, but it looks like times are also tough for those who went public before the economy soured. Cadence Pharmaceuticals has seen a dip in stock price from $9 to... |
| 17.02.2009 |
Cadence Pharmaceuticals Raises $86.6M In PIPE
| San Diego-based Cadence Pharmaceuticals, which licenses, develops, and commercializes biopharmaceuticals, said Tuesday that it has reached an agreement to raise approximately $86.6M from a group of venture capital investors. The publicly he... |
Reviews 0
